Search

everythinglearnresearchcommunity

for

Search:↓

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Melasma's causes include genetics, sun exposure, hormones, and oxidative stress, and understanding these can help create better treatments.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Combining micro-needling, LED therapy, and growth factors with Finasteride® significantly improves hair growth.

Both drugs lower DHT levels, with GI198745 being more effective.

Higher DHT in male baldness may protect against prostate cancer.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Plant extracts in shampoo improved hair thickness and density in men with hair loss.

Hormone levels in hair vary across the head, with the highest concentration of a key hormone linked to hair loss at the top.

Higher levels of heat shock protein 27 and lower levels of miR-1 can increase AR levels, leading to hair loss in men.

Finasteride reduces inflammation and improves immune response after trauma by altering hormone levels.

Finasteride lowers scalp and blood DHT levels, potentially treating male-pattern baldness.

People with androgenetic alopecia have different lipid levels in their blood, which vary between men and women, and may be linked to a higher risk of metabolic syndrome.

Some supplements and hormones can increase hair loss by raising DHT levels.

Women with a certain type of hair loss have more copper in the back of their head than the front, and treatment can normalize hair but not copper levels.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

Male pattern baldness involves hormone-related hair thinning, shorter hair, and inflammation.

D-004 may be a natural alternative to finasteride for treating enlarged prostate and male baldness.

Iron supplements may reverse premature graying in iron-deficient individuals; ingrown nails are common in diabetics with certain risk factors; topical finasteride may reduce scalp DHT as effectively as oral finasteride; monilethrix treatment is challenging but some medications can help.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

Higher IGF-1 levels in hair follicles link to better finasteride results for hair loss.

No strong link between testosterone or DHEAS levels and acne or hair loss in females.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Researchers developed a reliable way to measure hormones in urine, showing that a baldness treatment doesn't change hormone levels.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.